Work

Disialoganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma

Year: 2001

Type: article

Source: Medical and Pediatric Oncology

DOI: 10.1002/1096-911x(20010101)36:1<194::aid-mpo1046>3.0.co;2-b

Authors: Kim Kramer, William L. Gerald, Brian H. Kushner, Steven M. Larson, Meera Hameed, Nai-Kong V. Cheung

Institutions: Memorial Sloan Kettering Cancer Center, University of Medicine and Dentistry of New Jersey

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Food and Drug Administration, National Cancer Institute

Awards: G1117419297, NOVEL COMBINATION THERAPY OF NEUROBLASTOMA, G1836322885, INTRATHECAL RADIOIMMUNOTHERAPY OF CNS MALIGNANCIES, G683466769

OpenAlex ID: W1915556294

FWCI: 3.546

Cites: 5

Cited by: 98

Related to: 10